Sign in Check my fit
EN
Home / Horizon Europe / HORIZON-JU-CHIPS-2026-FT3-IA

IA Resilience call reinforcing Europe's strenght in health

Open now · HORIZON JU Innovation Actions · HORIZON-JU-CHIPS-2026-FT3-IA

Next cut-off
16 Sept '26
in 10 days
Per grant
€20M
the call's own average
Grants expected
1
projects that will be funded
Funding rate
70%
the rest is your own money

In context of Horizon Europe

This grant€20M
The track runs to the largest grant in Horizon Europe (€171M). The median across the 482 calls we publish is €5.3M, this one is above it.

What this call funds

Expected Outcome:

the proposals under this call are expected to address one or more of the following subjects :

  • Enhanced personalized monitoring, care and treatments, focusing on the development of highly customized healthcare solutions, including the required research and diagnostic tools, tailored to individual needs, covering various scenarios such as chronic disease management, physiotherapy, precision diagnosis, personalized medicine/treatment, pre- and postoperative care, and daily assistance in homes and common spaces. It also targets effective management of chronic diseases and elderly care through personalized monitoring and interventions facilitated by advanced sensor technologies and edge-to-cloud solutions. This includes the development and integration of solutions for Hospitalization at Home, enabling patients to receive complex, remotely supervised care using intelligent medical devices capable of sensing, analysing, and transmitting real-time data. This requires a continuum, from in-hospital diagnostics to robust, long-term patient support at home via AI-driven care pathways and hospitalization at home.
  • Prevention and treatment of diseases, allowing the improved scientific understanding, early detection and proactive prevention of diseases through scientific research, continuous monitoring, predictive analytics, and timely alerts, possibly powered by AI algorithms. This preventive approach enables early intervention and significantly reduces risks associated with many illnesses such as viral infections (e.g. epi- and pan demics), cardiovascular diseases, diabetes complications affecting the health of the young and old.

Trimmed here, the full scope, expected outcomes and award criteria are on the official topic page ↗.

What applying costs you

ItemEstimateNote
Drafting effort6–8 weekssingle submission
Partner search4–8 weeksruns in parallel, and it is the part that slips
Your own money€8.6M30% of project cost, over the project's life
Time to first payment6–9 monthscut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Where these conditions come from

Two kinds of row. Most are the sentence we read the condition from, quoted out of the call itself. Some say plainly that they are not a quotation but the programme's own rule for this type of action, the EU portal publishes a table of contents where the conditions should be, so for a Research and Innovation Action the rate comes from the rulebook rather than from the fiche.

ConditionQuoted from the call, or the rule behind it
Consortium sizeNot quoted from this call — Innovation Actions under the Horizon Europe rules are at least three independent legal entities from three different Member States or Associated Countries, at least one established in a Member State.
Funding rateNot quoted from this call — Innovation Actions under the Horizon Europe rules are funded at 70% of eligible costs for profit-making organisations, and 100% for non-profit legal entities — the rate shown here is the one that applies to a company.

Also open in HE

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit